Clinical trials
Cardiovascular Diseases clinical trials
Below are recruiting cardiovascular diseases clinical trials, each written for real people, not researchers. We’re tracking 794 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05644327Recruiting
Exercise program to improve sleep in Parkinson’s disease
This study looks at whether an exercise program can improve sleep problems in people with Parkinson’s disease. It’s mainly for those who already have poor sleep quality while taking stable Parkinson’s medicine.
Laval, QuebecAges 40 years+ - NCT05838950Recruiting
Short high-intensity exercise program for cardiometabolic health
This trial studies whether a structured, short high-intensity exercise program can improve health markers related to weight, blood sugar, and blood fats in young adults with obesity. It may help you see if this kind of exercise leads to measurable health improvements.
Syracuse, New YorkAges 18–25 - NCT05883878Recruiting
Personalized plan to prevent heart disease in high-risk adults
This trial looks at an individualized prevention approach for people who are at higher risk of heart and blood vessel problems. It aims to help lower future cardiovascular risk before heart disease develops.
Roma, ItaliaAges 40–69 - NCT06087848RecruitingPhase 1/Phase 2
StromaForte stem cell therapy for heart event prevention
This trial tests a stem cell product called StromaForte to see if it can reduce cardiovascular events like heart attacks in people with stable medical conditions. It may help if you have heart or blood vessel issues that have been stable for at least six months.
Nassau, The BahamasAges 25–85 - NCT06390189Recruiting
Inflammation resolution in heart and metabolic health
This study examines how your body naturally resolves inflammation, which is important for heart health and conditions like diabetes. It involves blood draws and tests to understand how inflammation works.
AarhusAges 18–75 - NCT06393478Recruiting
Southeastern Europe Microcirculation Registry
This study is collecting information about how well the tiny blood vessels in the heart work in people with chest pain. It helps doctors learn more about microcirculation problems and may lead to better treatments.
RijekaAges 18 years+ - NCT06494501RecruitingPhase 3
Preventing heart attacks in middle-aged adults with early plaque
This study tests whether starting cholesterol-lowering treatment early can prevent heart attacks in people aged 30-50 who already have early signs of artery plaque but no history of heart disease.
New York, New YorkAges 30–50 - NCT06552767Recruiting
Thrombosis and blood vessel inflammation study
This trial aims to learn more about blood clots, inflammation, and blood vessel problems. It may help researchers better understand these conditions and how they affect people.
Bethesda, MarylandAges 5–100 - NCT06570902Recruiting
Heart monitor vest after first bypass surgery
This study tests a wearable heart monitor vest (WCD) for people who have had their first coronary bypass surgery and have a weakened heart pump (ejection fraction below 35%). The vest watches for dangerous heart rhythms and can shock the heart back to normal if needed.
Bad Nauheim, HesseAges 18 years+ - NCT06580977Recruiting
Exercise and memory in Parkinson's disease
This study tests whether a supervised exercise program can improve memory and thinking in people with Parkinson's disease. You may be able to join if you are between 50 and 80, have mild to moderate Parkinson's, and can walk independently.
Heidelberg, Baden-WurttembergAges 50–80 - NCT06625073RecruitingPhase 4
SGLT2i for heart transplant recipients
This trial is testing a medication called SGLT2i (a type of diabetes drug that also helps the heart and kidneys) in people who have received a heart transplant. It aims to see if this drug can improve health after transplant.
Palo Alto, CaliforniaAges 18 years+ - NCT06642623RecruitingPhase 4
Study on heart and kidney health in type 2 diabetes
This trial tests enavogliflozin (a newer SGLT2 inhibitor) compared to older drugs (dapagliflozin or empagliflozin) to see how well it protects the heart and kidneys in people with type 2 diabetes.
SeoulAges 19 years+ - NCT06679777Recruiting
Swedish heart and lung imaging study 2
This study invites people who already took part in the first SCAPIS study to have follow-up heart and lung imaging. It helps researchers learn how these organs change over time.
GothenburgAges Any age - NCT06773169Recruiting
Testing an app for self-managing chronic conditions
This study tests a smartphone or computer app designed to help people with long-term health conditions like arthritis, heart disease, or stroke manage their own recovery. The goal is to see if using the app improves daily living and reduces disability.
Hamilton, OntarioAges 44–75 - NCT06806813Recruiting
Italian Fabry disease heart registry
This study is creating a registry of people with Fabry disease to better understand how it affects the heart. By joining, you help doctors learn more about the condition and improve care for future patients.
Chieti, Abruzzo/ChietiAges 2 years+ - NCT06873321RecruitingPhase 4
Blood thinners after leg artery surgery to prevent clots
This trial compares two blood-thinning strategies after leg artery surgery or angioplasty to prevent dangerous blood clots. Participants will receive either rivaroxaban plus aspirin or aspirin alone, and researchers will monitor for clots over 30 days.
Pernambuco, PernambucoAges Any age - NCT06888466Recruiting
Personalized heart health risk check
This trial looks at how learning about your genetic risk for heart disease might help prevent it. You will get a personalized report and guidance.
Roma, ItaliaAges 40 years+ - NCT06976073Recruiting
Skin imaging study using non-invasive scan
This trial uses a special camera to measure the composition and structure of the skin without any needles or cuts. It helps researchers understand how skin varies between people.
StockholmAges 18 years+ - NCT07048158Recruiting
A drink for heart health
This study tests a drink called 'Perfect Heartio' to see if it supports cardiovascular health in healthy adults. It may help improve heart function or reduce risk factors.
Cheras, Kuala LumpurAges 18 years+ - NCT07174622Recruiting
Long-term results for renal denervation study
This study tracks patients who have uncontrolled high blood pressure and are on a steady medication plan. It checks how kidney nerve treatment (renal denervation) works in real life over time.
Boston, MassachusettsAges 18 years+ - NCT07258524Recruiting
Vasculitis PET scan trial for heart disease risk
This trial uses a special PET scan to look at inflammation in blood vessels and check heart disease risk in people with active ANCA-associated vasculitis (AAV). It may help doctors understand how to better manage heart health during treatment.
EdinburghAges 18 years+ - NCT02770066Recruiting
Registry study of PTRA in difficult-to-control blood pressure
This study keeps track of people with renovascular hypertension (high blood pressure likely linked to blocked kidney arteries) who may receive a procedure called PTRA. It aims to understand who benefits and how kidney and heart outcomes change over time.
AalborgAges Any age - NCT02725060Enrolling by invitation
Study of autoimmune changes in postural tachycardia syndrome
This trial studies whether an autoimmune (immune system–related) process is involved in postural tachycardia syndrome (POTS), a condition where your heart rate rises when you stand. The study may help researchers understand what causes POTS and how it could be treated or monitored.
Oklahoma City, OklahomaAges 18–50 - NCT00753974Enrolling by invitation
Give blood and tissue samples during heart surgery
This study collects heart-related tissue or blood samples from people having cardiovascular surgery or procedures. It may help future researchers learn more about heart disease and improve care.
Lexington, KentuckyAges 18 years+
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cardiovascular diseases?
- Yes. Clin2 currently lists 794 recruiting cardiovascular diseases studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cardiovascular diseases trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cardiovascular diseases trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.